aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...

TEMPE, Ariz. – A team of researchers from Arizona State University and Mayo Clinic is showing how a staple of Earth science research can be used in biomedical settings to predict the course of disease ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous plasma cells build up in bone marrow, they crowd out healthy blood cells, ...

The model was found to be predictive and may help identify patients with multiple myeloma at a high risk of early disease progression. “In the past decade, due to the continuous maturation of ...

Multiple myeloma is a cancer of plasma cells, the antibody-making white blood cells that live in your bone marrow. When these cells turn abnormal and multiply, they crowd out healthy blood-forming ...

While it’s not as well-known as, say, leukemia or melanoma, multiple myeloma is the second most common blood cancer in adults, according to the Cancer Research Institute. “Multiple myeloma is a cancer ...

Multiple myeloma is the second most common blood cancer in the United States. Each year there are around 32,000 new cases and 13,000 deaths. We want those with multiple myeloma and their families to ...

Kenneth H. Shain, M.D., Ph.D.: Hello, and welcome to this CURE® Expert Connections®. I’m Dr. Shain. I’d like to welcome one of my patients, Marcella, who is ...